Gabales, Lulito, JR.. C.

HRN: 24-89-78  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CEFUROXIME 1.5GM (VIAL)
06/07/2024
06/14/2024
IV
1.5 G
Q8
UTI
Waiting Final Action 
06/11/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2024
06/18/2024
IV
500mg
Q8H
S/P ExLap
Waiting Final Action 
06/15/2024
CEFTRIAXONE 1G (VIAL)
06/15/2024
06/22/2024
IV
3g
24hrs
GUT Obstruction Enterolysis, Lavage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: